Literature DB >> 3194348

In vitro oxidation of mercury by the blood.

J B Hursh1, S P Sichak, T W Clarkson.   

Abstract

A method is described for studying the in vitro oxidation of mercury vapour by red blood cells at short times and with diminishing mercury vapour concentrations. It is found that for 40% red blood cell suspensions and 37 degrees at concentrations greater than about 6 ng mercury vapour/ml, the oxidation rate is zero order, and that at lower concentrations the rate changes to first order. The effect of temperature and of added hydrogen peroxide are studied. Results are considered in terms of the generally accepted belief that the catalase-compound I system is the main path of oxidation. If the results obtained in vitro in these experiments apply in vivo to man, it follows that inhaled mercury is carried in the blood to the brain and other organs primarily as dissolved vapour rather than as inorganic mercury ions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3194348     DOI: 10.1111/j.1600-0773.1988.tb00952.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  4 in total

1.  Glutamate: a potential mediator of inorganic mercury neurotoxicity.

Authors:  J Albrecht; E Matyja
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

2.  Astrocytes as potential modulators of mercuric chloride neurotoxicity.

Authors:  M Aschner; K J Mullaney; M N Fehm; D E Wagoner; D Vitarella
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

3.  Expression of a high-affinity form of UDP-glucuronosyltransferase in human foetal liver cells in culture on exposure to mercuric chloride.

Authors:  T M Tan; K P Wong; K H Sit
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

4.  Changes of the Na/K ATPase activity in the cerebral cortical microvessels of rat after single intraperitoneal administration of mercuric chloride: histochemical demonstration with light and electron microscopy.

Authors:  G Szumańska; R Gadamski; J Albrecht
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.